Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis

Despite advances in drug development, life expectancy in idiapathic pulmonary arterial hypertension (IPAH) remains unacceptable. Contemporary IPAH characterization is based on criteria that may not adequately capture disease heterogeneity and may be proposed as a possible explanation for why patient's outcome is still unfavorable.

Source: The Journal of Heart and Lung Transplantation - January 20, 2020 Category: Transplant Surgery Authors: Roberto Badagliacca, Franz Rischard, Silvia Papa, Saad Kubba, Rebecca Vanderpool, Jason X.-J. Yuan, Joe G.N. Garcia, Sophia Airhart, Roberto Poscia, Beatrice Pezzuto, Giovanna Manzi, Cristiano Miotti, Federico Luongo, Gianmarco Scoccia, Susanna Sciomer, R Tags: Original Clinical Science Source Type: research